- Fellowship in Transfusion Medicine
- Specialists in Blood Bank
- Other Training Opportunities
- Annual Symposiums
- DTM Presentations
- Molecular Roundtable Discussions
Department of Transfusion Medicine
Thirty-Ninth Annual Symposium
Description: This program is designed to provide attendees with practical information about recent developments, current practices, controversies and laboratory management issues relative to transfusion medicine.
Who Should Attend: This program will be of interest to all healthcare providers who participate in the collection, production, transfusion and monitoring of blood products.
Upon the completion of this activity, participants should be able to:
- List the benefits and potential risks of transfusion of convalescent plasma as treatment of COVID19.
- Describe comparative effectiveness studies and the flaws of such studies with regard to transfusion triggers.
- Report on the current application and benefits of CAR T cell therapy.
- State how large databases can be used to study the impact of blood donor characteristics, blood product quality and policy changes by the blood supplier on patient outcomes.
- Conclude the design and the logistics around implementation of a randomized controlled trial of COVID19 convalescent plasma in the span of seven weeks.
- Summarize the current transfusion practices and educational needs in developing countries.
- Develop appropriate patient and donor care strategies from examples described during case reviews.
- Review the properties, benefits and indicates of freeze-dried platelets.
- Discuss how the American Red Cross provided products during the COVID pandemic.
Level of Instruction
Intermediate to Advanced
The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of ARCBS. Information is presented for educational purposes only.
The American Red Cross Biomedical Services (ARCBS) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the American Red Cross Biomedical Services (ARCBS) and the National Institutes of Health. ARCBS is accredited by the ACCME to provide continuing medical education for physicians and provides continuing education credits through its SUCCESS™ Program.
The American Red Cross Biomedical Services designates this educational activity for a maximum of 5.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity. A maximum of 5.75 SUCCESS™ CEU credits will be awarded to laboratory professionals participating in this activity.
The American Red Cross offers the SUCCESS™ continuing education program to blood bankers and physicians. Attendees of the Symposium will receive certificates certifying their participation via email after the Symposium.
All faculty participating in ARCBS continuing medical education programs are expected to disclose to learners whether they do or do not have any real or apparent conflicts(s) of interest or other relationships related to the content of their presentation(s). Faculty are also expected to disclose off-label and/or investigational uses of products under discussion.
We gratefully acknowledge Immucor for providing an educational grant in support of this continuing medical education activity.
NOTE: PDF documents require the free Adobe Reader.
This page last updated on 07/06/2020